These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 17622114

  • 1. Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems.
    Nalluri BN, Chowdary KP, Murthy KV, Becket G, Crooks PA.
    AAPS PharmSciTech; 2007 May 11; 8(2):Article 36. PubMed ID: 17622114
    [Abstract] [Full Text] [Related]

  • 2. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV, Chotai NP, Patel MP.
    Pharmazie; 2008 Apr 11; 63(4):275-81. PubMed ID: 18468386
    [Abstract] [Full Text] [Related]

  • 3. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.
    Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM.
    AAPS PharmSciTech; 2004 Jul 27; 5(4):e59. PubMed ID: 15760056
    [Abstract] [Full Text] [Related]

  • 4. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W, Akkaramongkolporn P, Ngawhirunpat T, Rojanarata T, Opanasopit P.
    Drug Dev Ind Pharm; 2015 Jun 27; 41(6):1006-16. PubMed ID: 24865111
    [Abstract] [Full Text] [Related]

  • 5. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA, Obaidat RM.
    Acta Pharm; 2011 Mar 27; 61(1):83-91. PubMed ID: 21406346
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł, Kasperek R, Poleszak E.
    Polim Med; 2014 Mar 27; 44(4):231-5. PubMed ID: 25932904
    [Abstract] [Full Text] [Related]

  • 10. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 27; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 11. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS, Vavia PR.
    Drug Dev Ind Pharm; 2011 Nov 27; 37(11):1318-28. PubMed ID: 21506882
    [Abstract] [Full Text] [Related]

  • 12. Development and optimization of a meloxicam/β-cyclodextrin complex for orally disintegrating tablet using statistical analysis.
    Ainurofiq A, Choiri S.
    Pharm Dev Technol; 2018 Jun 27; 23(5):464-475. PubMed ID: 27875913
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique.
    El-Maradny HA, Mortada SA, Kamel OA, Hikal AH.
    Acta Pharm; 2008 Dec 27; 58(4):455-66. PubMed ID: 19103579
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies.
    Chowdary KP, Nalluri BN.
    Drug Dev Ind Pharm; 2000 Nov 27; 26(11):1217-20. PubMed ID: 11068697
    [Abstract] [Full Text] [Related]

  • 17. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
    Shende PK, Gaud RS, Bakal R, Patil D.
    Colloids Surf B Biointerfaces; 2015 Dec 01; 136():105-10. PubMed ID: 26364091
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Formulation development of intermediate release Nimesulide tablets by CCRD for IVIVC studies.
    Hanif M, Shoaib MH, Yousuf RI, Sattar S, Nadeem M, Hussain L, MZia MU, Muhammad IN, Uzair M, Qadir I.
    Pak J Pharm Sci; 2014 Jul 01; 27(4):785-92. PubMed ID: 25015441
    [Abstract] [Full Text] [Related]

  • 20. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
    Jain SK, Gupta Y, Jain A, Amin S.
    Curr Drug Deliv; 2008 Jul 01; 5(3):207-14. PubMed ID: 18673264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.